Pornlada Likasitwatanakul

22PUBLICATIONS
126CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersSolid tumoursCancer geneticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jun 01, 2026
A Watershed Moment in the Perioperative Treatment of Prostate Cancer.

|Oct 26, 2025
HLA class I expression shapes the tumor immune microenvironment and influences prognosis in prostate cancer.

Pornlada Likasitwatanakul, Carissa Besonen, Alexander K Tsai

|Oct 16, 2025
Novel MAML2 Fusions in Human Malignancy.

Takefumi Komiya, Kieran Sweeney, Chao H Huang

|Aug 14, 2025
CH Mutations in 16,812 Advanced Cancer Patients-Letter.

Emmanuel S Antonarakis, Katherine L Nathanson, Kim A Reiss

|Aug 12, 2025
SOX2 utilizes FOXA1 as a heteromeric transcriptional partner to drive proliferation in therapy-resistant prostate cancer.

John T Phoenix, Audris Budreika, Devin A Schmeck

|May 14, 2025
Germline DNA Repair Gene Mutations and Clonal Hematopoiesis (CH) in 24,849 Patients with BRCA-Associated Cancers.

Catherine H Marshall, Ali T Arafa, Ellen Jaeger

Pageof 4

Frequent Collaborators

4 joint publications

Andrew Elliott

3 joint publications

Himisha Beltran

3 joint publications

Pedro C Barata

3 joint publications

Scott M Dehm